Baseline tumor size as an independent prognostic factor for overall survival in patients with metastatic melanoma treated with the anti-PD-1 monoclonal antibody MK-3475 Meeting Abstract
| Authors: | Joseph, R. W.; Elassaiss-Schaap, J.; Wolchok, J. D.; Joshua, A. M.; Ribas, A.; Hodi, F. S.; Hamid, M.; Robert, C.; Daud, A.; Hwu, W. J.; Kefford, R.; Hersey, P.; Weber, J. S.; Patnaik, A.; De Alwis, D. P.; Perrone, A. M.; Kang, S. P.; Ebbinghaus, S.; Anderson, K. M.; Gangadhar, T. C. |
| Abstract Title: | Baseline tumor size as an independent prognostic factor for overall survival in patients with metastatic melanoma treated with the anti-PD-1 monoclonal antibody MK-3475 |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613202906 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.3015 |
| Notes: | Meeting Abstract: 3015 -- Source: Wos |
